A Study of the Efficacy and Safety of FXS6837 Capsules Compared to Eculizumab for 24 Weeks in Patients With PNH.
Clinical trial NCT07747090 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07747090
- Sponsor
- Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-10
- Primary completion
- 2028-05-05
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.